Luke Timmerman of Xconomy recently wrote an excellent article where he explained why Twitter matters now in biotech, and why executives can’t ignore it anymore. In the article, Luke explains his initial hesitation in using the social media tool by saying, “it seemed like a good way to fragment my attention span into a million little pieces by consuming gossip and trivia, diluting the focus needed to produce in-depth biotech news and feature stories on tight deadlines.” Luke then goes on to admit that he was wrong stating, “wrong, wrong, wrong… I do still have some concerns about what real-time connectivity is doing to humanity… I’ve come around to the idea that Twitter, used wisely, has potential to be a great force for good in biotech.”
Check out Luke’s article in Xconomy in its entirety to read his analysis of Twitter and its use in the biotechnology industry.
